Klausner Urges Emphasis On Research, Warns Against Shift To Health Programs.
Gregory Reaman Elected Chairman, C.O.G.; NCI Seeks Nominations For Consumer Group. “We Need A Long-Term Commitment” To Discovery.
First NCI Director To Resign Due To Presidential Election?
EntreMed Begins Pilot Phase II Trial Of Small Molecule Angiogenesis Inhibitor.
Perot Systems To Provide IT Support For US Oncology Enterprise Applications.
Bayer’s HER-2/neu Blood Test Cleared By FDA For Marketing.
Firm Wins Patent For Method, Apparatus For Cryoablation.
Trending Stories
- The Directors: Tom Lynch and Skip Burris on how NIH funding cuts imperil biopharma innovation—and cost patient lives
In a time of uncertainty, “react to the knowns, not the fear” - How MD Anderson and Texas Children’s made plans to build a $1 billion pediatric cancer hospital—one of the world’s largest
- In the Headlines: MD Anderson’s Pisters on doing “something gigantic for pediatric cancer”
- As cancer scientists, we must change how we engage with the public on the impact of NIH cuts
What the scientific method obscures - In weekly vigils, current and former NIH staff grieve the impact of Trump cuts
The Saturday gatherings at NIH’s Metro station are part graveside service, part street theater - Scaling excellence: How City of Hope is transforming cancer care delivery
